Bridging the gap: academia, industry and FDA convergence for nanomaterials
- 14 September 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in Drug Development and Industrial Pharmacy
- Vol. 46 (11), 1735-1746
- https://doi.org/10.1080/03639045.2020.1821055
Abstract
Nano-medicine is the fastest growing field in pharmaceutical industry today. However, there still exist several hurdles preceding its clinical translation. This review provides insights on the guidelines for nanomaterials provided by the US-FDA (United States Food and Drug Administration), various approval pathways and also addresses the lacunae between academic research, pharmaceutical industry and US-FDA through an attempt to overcome the hurdle to its clinical translation. We have also emphasized various ways to overcome the described barriers which will provide the readers a brief understanding over the critical aspects where the scope of the guidelines may need to be revisited in order to exhibit their successful clinical translation from academic research to commercial feasibility.Keywords
This publication has 48 references indexed in Scilit:
- Modified and derived ethanol injection toward liposomes: development of the processJournal of Liposome Research, 2012
- Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapyJournal of Nanobiotechnology, 2012
- Challenges in Development of Nanoparticle-Based TherapeuticsThe AAPS Journal, 2012
- Physical and chemical stability of drug nanoparticlesAdvanced Drug Delivery Reviews, 2011
- Precise Measurement of the Size of Nanoparticles by Dynamic Light Scattering with Uncertainty AnalysisParticle & Particle Systems Characterization, 2008
- Freeze-drying of nanoparticles: Formulation, process and storage considerationsAdvanced Drug Delivery Reviews, 2006
- Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticlesEuropean Journal of Pharmaceutical Sciences, 2005
- Process analytical technologies in the pharmaceutical industry: the FDA’s PAT initiativeAnalytical and Bioanalytical Chemistry, 2005
- Polymers in drug deliveryCurrent Opinion in Chemical Biology, 2001
- Liposomes as a Drug Delivery SystemDrug Development and Industrial Pharmacy, 1989